1. Home
  2. BLLN vs DNN Comparison

BLLN vs DNN Comparison

Compare BLLN & DNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BLLN

BillionToOne Inc.

N/A

Current Price

$80.12

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Logo Denison Mines Corp (Canada)

DNN

Denison Mines Corp (Canada)

HOLD

Current Price

$3.44

Market Cap

3.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
DNN
Founded
2016
1954
Country
United States
Canada
Employees
713
N/A
Industry
Medical Specialities
Other Metals and Minerals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.3B
IPO Year
N/A
1998

Fundamental Metrics

Financial Performance
Metric
BLLN
DNN
Price
$80.12
$3.44
Analyst Decision
Buy
Strong Buy
Analyst Count
7
1
Target Price
$129.57
$6.50
AVG Volume (30 Days)
318.7K
38.4M
Earning Date
03-04-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$45.89
$237.62
Revenue Next Year
$30.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$61.96
$1.08
52 Week High
$138.70
$4.43

Technical Indicators

Market Signals
Indicator
BLLN
DNN
Relative Strength Index (RSI) 54.69 40.07
Support Level $63.98 $2.56
Resistance Level $86.01 $4.42
Average True Range (ATR) 5.61 0.23
MACD 1.30 -0.08
Stochastic Oscillator 75.47 21.43

Price Performance

Historical Comparison
BLLN
DNN

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About DNN Denison Mines Corp (Canada)

Denison Mines Corp is a uranium exploration and development company focused on the Athabasca Basin region of northern Saskatchewan, Canada. The company holds a noteworthy 95% interest in its flagship Wheeler River Uranium Project, the undeveloped uranium project located in the infrastructure-rich eastern part of the Athabasca Basin. Additionally, it is involved in mine decommissioning and environmental services through its Closed Mines group, which manages the Elliot Lake reclamation projects and offers third-party post-closure mine care and maintenance services. The Company operates in two main segments: the Mining segment and the Corporate and Other segment. The majority of revenue is generated from the mining segment.

Share on Social Networks: